NASDAQ:RLAY

Relay Therapeutics Stock Forecast

etoro logo Buy RLAY
*Your capital is at risk
$18.71
-1.03 (-5.22%)
At Close: Jun 30, 2026
AI Analysis AI Analysis of RLAY AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RLAY to Watchlist?
Some Reasons Why To Add RLAY:
  • +431.5% price growth over the last year
  • +128.7% YTD performance
  • Low bankruptcy risk (Altman Z-Score: 29.57)
PDF

Is Relay Therapeutics Inc. stock still a buy after falling -5.22% on Tuesday?
(Updated on Jun 30, 2026)

Buy or Hold candidate since Jun 11, 2026 Gain 31.39%

The Relay Therapeutics Inc. stock price fell by -5.22% on the last day (Tuesday, 30th Jun 2026) from $19.74 to $18.71. During the last trading day the stock fluctuated 6.48% from a day low at $18.66 to a day high of $19.87. The price has risen in 8 of the last 10 days and is up by 25.07% over the past 2 weeks. Volume has increased on the last day by 2 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 6 million shares were bought and sold for approximately $106.89 million.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $19.79 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 17.66% during the next 3 months and, with a 90% probability hold a price between $15.20 and $23.28 at the end of this 3-month period.

RLAY Signals & Forecast

The Relay Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $18.23 and $14.79. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -5.22%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Relay Therapeutics Inc. stock

Relay Therapeutics Inc. finds support from accumulated volume at $18.56 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.21 between high and low, or 6.48%. For the last week, the stock has had daily average volatility of 7.03%.

The Relay Therapeutics Inc. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $17.88 (-4.42%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 78 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (RLAY) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect Relay Therapeutics Inc. to open at $19.08, and during the day (based on 14 day Average True Range), to move between $18.15 and $19.27, which gives a possible trading interval of +/-$1.12 (+/-6.17%) up or down from last closing price. If Relay Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 6.17% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $18.56 (0.80%) than the resistance at $19.74 (5.51%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Relay Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Relay Therapeutics Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.640 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 1, 2026 - $19.08 ( 1.98%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RLAY Performance

Trading levels for RLAY

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 20.29 8.44%
R2 19.83 5.97%
R1 19.54 4.45%
Price 18.71
S1 18.62 -0.493%
S2 18.33 -2.02%
S3 17.87 -4.49%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 19.74 5.51%
Price 18.71
S1 18.56 -0.80%
S2 15.88 -15.13%
S3 15.70 -16.09%

FAQ

What is the symbol for Relay Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Relay Therapeutics Inc. is RLAY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Relay Therapeutics Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Relay Therapeutics Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

How to buy Relay Therapeutics Inc. Stock?
Relay Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Relay Therapeutics Inc. Stock.

What's the current price of Relay Therapeutics Inc. Stock?
As of the end of day on the Jun 30, 2026, the price of an Relay Therapeutics Inc. (RLAY) share was $18.71.

What is the 52-week high and low for Relay Therapeutics Inc. Stock?
The 52-week high for Relay Therapeutics Inc. Stock is $19.94 and the 52-week low is $3.03.

What is the market capitalization of Relay Therapeutics Inc. Stock?
As of the Jun 30, 2026, the market capitalization of Relay Therapeutics Inc. is 3.275B.

When is the next earnings date for Relay Therapeutics Inc.?
The upcoming earnings date for Relay Therapeutics Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT RELAY THERAPEUTICS INC.
Relay Therapeutics
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhibitor of fibroblast growth factor receptor 2 (FGFR2), which is in a first-in-human clinical trial for pa...
GOLDEN STAR
Ticker Change Signal Date
IIIV
$20.09
5.03% Jun 25
X
XMAX
$8.34
7.31% Jun 24
NMRK
$15.02
1.60% Jun 24
JLL
$299.78
4.44% Jun 24
CAG
$13.43
4.06% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE